Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lot-to-Lot Consistency of CYD Dengue Vaccine in Healthy Adults
NCT01134263Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2010
- Primary completion
- Nov 2012
- Modality
- Live Attenuated Vaccines, Recombinant Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Cyd dengue virus serotype 1 live (attenuated) antigen in dengue fever, sponsored by Sanofi. Started Oct 2010; status: completed.
02
Drugs
Cyd dengue virus serotype 1 live (attenuated) antigen
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT01134263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134263.